Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2017, Vol. 37 Issue (6): 22-30    DOI: 10.13523/j.cb.20170604
    
Effect of CX3CR1 on Human Hepatocellular Carcinoma Cells and Its Mechanism
FAN Meng-tian, CHEN Si-cheng, GUO Yang-liu, LI Ya, SUN Yan-ting, LI Wang, SHI Qiong
Key laboratory of Clinical Laboratory Diagnostics, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China
Download: HTML   PDF(2391KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Aim:To investigate the effect of CX3CR1 on the proliferation migration and invasion abilities of hepatocellular carcinoma(HCC) cell lines and its mechanism. Methods:The expression of CX3CR1 at mRNA and protein levels of 7721,HepG2 and human normal liver epithelial cells LO2 was detected by Q-PCR and Western blot. The 7721 cells were transfected with the overexpression plasmid of CX3CR1;the HepG2 cells were transfected with siRNA of CX3CR1,and the expression of CX3CR1 at mRNA and protein levels were detected by Q-PCR and Western blot. The cell proliferation ability was detected by MTT and clone formation assay. The migration and invasion ability were detected by Wound-healing and Transwell assays. The protein levels of PI3K/AKT and MAPK/ERK were detected by Western blot. Results:The expression of CX3CR1 was lower in 7721 cells than that in HepG2 cells. After overexpression plasmid was transfected into 7721 cells,the expression of CX3CR1 was up-regulated; cell proliferation migration and invasion abilities were increased. Meanwhile, the levels of p-ERK and p-AKT were up-regulated. After siRNA was thansfected into HepG2 cells,the expression of CX3CR1 was down-regulated,and cell proliferation, migration and invasion abilities were decreased, with the levels of p-ERK and p-AKT down-regulated. Conclusion:CX3CR1 can promote the proliferation, migration and invasion abilities of hepatocellular carcinoma(HCC) cells. The activation of PI3K/AKT and MEK/ERK signaling pathway may play an important role in these processes.

Key wordsCX3CR1      Proliferation      Migration      Hepatocellular carcinoma      Invasion     
Received: 13 December 2016      Published: 25 June 2017
ZTFLH:  Q71  
Cite this article:

FAN Meng-tian, CHEN Si-cheng, GUO Yang-liu, LI Ya, SUN Yan-ting, LI Wang, SHI Qiong. Effect of CX3CR1 on Human Hepatocellular Carcinoma Cells and Its Mechanism. China Biotechnology, 2017, 37(6): 22-30.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20170604     OR     https://manu60.magtech.com.cn/biotech/Y2017/V37/I6/22

[1] Moriguchi M, Umemura A.Current status and future prospects of chemotherapy for advanced hepatocellular carcinoma. Clin J Gastroenterol, 2016,9(4):184-190.
[2] Kufareva I.Chemokines and their receptors:insights from molecular modeling and crystallography. Curr Opin Pharmacol, 2016, 30:27-37.
[3] Huang F,Geng X P.Chemokines and hepatocellular carcinoma.World Journal of Gastroenterology,2010, 16(15):1832-1836.
[4] Ren H, Zhao T, Sun J.The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma. J Cell Biochem,2013, 114(11):2603-2611.
[5] Yao X, Qi L, Chen X.Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.Urologic Oncology,2013, 32(2):162-170.
[6] Lv C Y, Zhou T, Chen W.Preliminary study correlating CX3CL1/CX3CR1 expression with gastric carcinoma and gastric carcinomaperineural invasion. World Journal of Gastroenterology, 2014, 20(15):4428-4432.
[7] Liu J F, Tsao Y T, Hou C H.Fractalkine/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1/PI3K/Akt/NF-κB pathway in human osteosarcoma. Oncotarget, 2016, Aug 12.
[8] Shao Y, Guan J Z. Advances in the treatment of primary liver.Infectious Disease Information, 2016,29(4):248-252.
[9] Brunot A, Le Sourd S. Hepatocellular carcinoma in elderly patients:challenges and solutions.J Hepatocell Carcinoma,2016, 3:9-18.
[10] Shah A D, Bouchard M J.Interstitial fluid flow increases hepatocellular carcinoma cell invasion through CXCR4/CXCL12 and MEK/ERK signaling. PLoS One,2015, 10(11):e0142337.
[11] Du D, Liu Y. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma. Int J Mol Sci, 2014,15(4):6441-6452.
[12] Sadeghi M, Lahdou I.Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. Br J Cancer, 2015,113(5):756-762.
[13] Yeung O W, Lo C M. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J Hepatol, 2015, 62(3):607-616.
[14] Jamieson W L. CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow:potential role in prostate cancer bone tropism. Cancer Res, 2008, 68(6):1715-1722.
[15] Luo Wen, Lin Yuanlong. miRNA-296-3p modulates chemosensitivity of lung cancer cells by targeting CX3CR1. Am J Transl Res, 2016, 8(4):1848-1851.
[1] LI Shi-rong,CHEN Yang-qin,ZHANG Chun-pan,QI Wen-jie. RS4651 Inhibits the EMT of Mouse Hepatocyte AML12 via Upregulating SMAD7[J]. China Biotechnology, 2021, 41(7): 1-9.
[2] OUYANG Qin,LI Yan-meng,XU An-jian,ZHOU Dong-hu,LI Zhen-kun,HUANG Jian. GTF2H2 Affects the Proliferation and Migration of Hep3B Hepatocellular Carcinoma Cells by Mediating AKT Signal Pathway[J]. China Biotechnology, 2021, 41(6): 4-12.
[3] TAO Shou-song,REN Guang-ming,YIN Rong-hua,YANG Xiao-ming,MA Wen-bing,GE Zhi-qiang. Knockdown of Deubiquitinase USP13 Inhibits the Proliferation of K562 Cells[J]. China Biotechnology, 2021, 41(5): 1-7.
[4] LU Yu-xiang,LI Yuan,FANG Dan-dan,WANG Xue-bo,YANG Wan-peng,CHU Yuan-kui,YANG Hua. The Role and Expression Regulation of MiR-5047 in the Proliferation and Migration of Breast Cancer Cells[J]. China Biotechnology, 2021, 41(4): 9-17.
[5] XU An-jian,LI Yan-meng,WU Shan-na,ZHANG Bei,YAO Jing-yi. PHP14 Plays a Role in Epithelial-Mesenchymal Transition of AML-12Cell Through Interaction with Vimentin[J]. China Biotechnology, 2021, 41(2/3): 1-6.
[6] TANG Min,WAN Qun,SUN Shi-lei,HU Jing,SUN Zi-jiu,FANG Yu-ting,ZHANG Yan. The Effects of Hsa-miR-5195-3p on the Proliferation, Migration and Invasion of Human Cervical Cancer SiHa Cells[J]. China Biotechnology, 2020, 40(4): 17-24.
[7] YANG Dan,TIAN Hai-shan,LI Xiao-kun. Research Progress of Fibroblast Growth Factor 5[J]. China Biotechnology, 2020, 40(3): 117-124.
[8] GU Hao,GUO Xin-yu,DU Jing-jing,ZHANG Pei-wen,WANG Ding-guo,LIAO Kun,ZHANG Shun-hua,ZHU Li. The Effect of miR-186-5p on the Proliferation and Differentiation of 3T3-L1 Preadipocyte[J]. China Biotechnology, 2020, 40(3): 21-30.
[9] HE Xiu-juan,HU Feng-zhi,LIU Qiu-li,LIU Yu-ping,ZHU Ling,ZHENG Wen-yun. CRISPR / Cas9 Gene Editing of QSOX1 in Breast Cancer Cells and Its Effect on the Proliferation and Invasion[J]. China Biotechnology, 2020, 40(11): 1-9.
[10] ZHU Ying,FAN Meng-tian,LI Ju-qiong,CHEN Bin,ZHANG Meng-hao,WU Jing-hong,SHI Qiong. Effect of Chemokine Receptor CX3CR1 on Osteogenic Differentiation of Human Aortic Valve Interstitial Cells[J]. China Biotechnology, 2019, 39(8): 7-16.
[11] Lu WANG,Li-yuan YANG,Yu-ting TANG,Yao TAO,Li LEI,Yi-pei JING,Xue-ke JIANG,Ling ZHANG. Effects of PKM2 Knockdown on Proliferation and Apoptosis of Human Leukemia Cells and Its Potential Mechanism[J]. China Biotechnology, 2019, 39(3): 13-20.
[12] DUAN Li-mei,YANG Jin-xiao,LIU Jia-yu,ZHENG Yong-bo,WU Xiao-hou,LUO Chun-li. shPLCε Inhibits Serine/Glycine Metabolism and Proliferation of Prostate Cancer via YAP Signaling Pathway[J]. China Biotechnology, 2019, 39(11): 1-12.
[13] Qun WAN,Meng-yao LIU,Jing XIA,Li-yao GOU,Min TANG,Shi-lei SUN,Yan ZHANG. The Effects of LncRNA SNHG3 on the Proliferation, Migration and Invasion of Human Breast Cancer MCF-7 Cells[J]. China Biotechnology, 2019, 39(1): 13-20.
[14] Li-yao GOU,Meng-yao LIU,Jing XIA,Qun WAN,Chi-lei SUN,Min TANG,Yan ZHANG. The Effects of Bone Morphogenetic Protein 9(BMP9) on the Proliferation and Migration of Human Bladder Cancer BIU-87 Cells[J]. China Biotechnology, 2018, 38(5): 10-16.
[15] Yi-man LI,Qin ZHOU. The Effects of Herpud1 on Metanephric Mesenchymal Cells and Its Mechanism[J]. China Biotechnology, 2018, 38(3): 9-15.